NCT04127838

Low Vision Occupational Therapy in Parkinson's Disease

Completed NA Last updated 7 June 2022

What this trial tests

NA trial testing Low Vision Occupational Therapy in Parkinson Disease in 33 participants. Completed in 3 June 2022.

Timeline

16 October 2019

Primary endpoint
13 May 2022

3 June 2022

Quick facts

Lead sponsor	University of Alabama at Birmingham
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	33
Start date	16 October 2019
Primary completion	13 May 2022
Estimated completion	3 June 2022
Sites	1 location across United States

Drugs / interventions tested

• Low Vision Occupational Therapy

Conditions studied

• Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

University of Alabama at Birmingham

Who can join

18 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this study is to determine whether low-vision occupational therapy improves quality of life in Parkinson's Disease (PD) patients. Low-vision occupational therapy has not been previously studied in PD patients, and we suspect that this is a beneficial treatment option for PD patients as vision impairment is common in the PD patient population. Our primary objective will assess whether quality of life was improved following a low-vision occupational therapy session.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.